Edgen Stock·Nov 22 2025, 12:27Back
CytomX Therapeutics Stock Surges 29.1% on Positive Phase 1 Data for Cancer Drug CX-801
Edgen Stock·Nov 22 2025, 12:27
[1] CytomX Therapeutics, Inc. to Present CX-801 Phase 1 Monotherapy ... (https://www.marketscreener.com/news/cytomx-th ...)[2] CytomX to Present CX-801 Phase 1 Biomarker Data at SITC (https://www.stocktitan.net/news/CTMX/cytom-x- ...)[3] CytomX Therapeutics Announces Phase 1 Data for CX-801 ... (https://www.quiverquant.com/news/CytomX+Thera ...)
